Congress orders HHS to review lung cancer research for women and underserved groups, and ways to expand screening
Stalled
No legislative action in over 90 days.
How this policy affects specific groups of people
Received in the Senate. Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 380.
The bill is now on the schedule for the full chamber to consider. It's in line for debate and a vote.
Motion to reconsider laid on the table Agreed to without objection.
On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H3020)
The House fast-tracked this bill — limited debate, no amendments allowed, but needs two-thirds support to pass.
Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote.
The House fast-tracked this bill — limited debate, no amendments allowed, but needs two-thirds support to pass.
DEBATE - The House proceeded with forty minutes of debate on H.R. 2319.
No votes have been recorded for this legislation yet.
Recaps the Senate HELP Committee’s Jan. 15 action advancing S.1157, including that it would require an interagency review to improve outcomes for women.
Bill status page noting Jan. 28, 2026 placement on the Senate Legislative Calendar for S.1157 (Women and Lung Cancer Research and Preventive Services Act of 2025).
Bill status page noting House action placing H.R.2319 on the Union Calendar (Nov. 18, 2025), with summary of the interagency review requirements.
Document Type
Congressional Bill
Official Title
Women and Lung Cancer Research and Preventive Services Act of 2025
Analysis generated by AI. Always verify with official sources.